Tabuk Pharmaceuticals Executive and Leadership Team

Ismail Shehada, the Chief Executive Officer at Tabuk Pharmaceuticals, directs the overarching corporate strategy and operational execution. Shehada guides the company's expansion within regulated MENA markets, ensuring adherence to quality standards and cost-effectiveness. This leadership role involves aligning all departments toward achieving Tabuk Pharmaceuticals' mission of delivering essential medicines. Overseeing market penetration and product portfolio development, Shehada drives the company's growth in key therapeutic areas such as GI and diabetes, cardiovascular, musculoskeletal, respiratory, infection, and central nervous system pharmaceuticals. The strategic vision set by Ismail Shehada ensures Tabuk Pharmaceuticals maintains its competitive edge and commitment to public health across the region.

Doaa Bugis, the Chief Executive Officer Office Manager at Tabuk Pharmaceuticals, manages the executive office's daily operations and administrative functions. Bugis ensures seamless communication and coordination between the CEO's office and other departments, facilitating efficient workflow and decision-making processes. This role is critical for supporting the strategic initiatives spearheaded by the Chief Executive Officer. Doaa Bugis oversees scheduling, correspondence, and the preparation of essential documentation, directly contributing to the smooth execution of Tabuk Pharmaceuticals' business objectives. The effective management provided by Bugis supports the company's commitment to delivering quality, cost-effective pharmaceuticals across the MENA region.

Saad Stephan, the Chief Financial Officer at Tabuk Pharmaceuticals, directs all financial planning, management, and reporting activities. Stephan ensures robust fiscal health and optimizes financial performance to support the company's mission of delivering cost-effective pharmaceuticals. This critical role involves managing budgets, overseeing investments, and ensuring compliance with financial regulations across the MENA region. Saad Stephan guides the financial strategy to sustain growth and profitability, particularly in therapeutic areas like infection and central nervous system treatments. The financial oversight provided by Stephan is essential for Tabuk Pharmaceuticals' continued ability to provide quality, affordable medicines.

Hatem Reda, the Chief Marketing Officer at Tabuk Pharmaceuticals, architects and executes comprehensive marketing strategies to expand market reach within the MENA region. Reda drives brand visibility and product adoption across major therapeutic areas, including GI and diabetes, cardiovascular, and respiratory treatments. This leadership position involves analyzing market trends and identifying opportunities for growth in regulated territories. Hatem Reda oversees the development of promotional campaigns and market access initiatives, ensuring Tabuk Pharmaceuticals' cost-effective, quality products reach target demographics. The marketing efforts directed by Reda are fundamental to reinforcing the company's position as a leading generic pharmaceutical provider.